zFree
The Biggest Investor Event in Healthcare Starts Next Week
Recap - Investors descend en masse on San Francisco next week for the annual JP Morgan healthcare conference, a major event for the sector that historically generates … Continue Reading
Read Now
Arena Pharmaceuticals Climbs on Me-Too Autoimmune Drug
Insights - Arena Pharmaceuticals (ARNA) was up as much as 40% on Wednesday with the release of phase I data for APD334.
Read Now
Here’s What bluebird bio Investors Should Know about Sickle Cell Disease
Research - By Zack Fink and guest contributor Dan Marks Bluebird bio (BLUE) will release data from the first Sickle Cell Disease patient treated with its LentiGlobin gene therapy … Continue Reading
Read Now
Kite Pharma Inks Deal with Amgen in Move Towards ‘Platform’ Model
Insights - Shortly before the bell on Monday morning, Kite Pharma (KITE) announced an immunotherapy collaboration and licensing agreement with one of biotech’s juggernauts, Amgen (AMGN), to advance … Continue Reading
Read Now2014 was Stellar for Biotech. Here’s to an Even Better 2015
Insights - 2014 was a stellar year in biotech, for investors as well as patients. Here’s to an even better 2015. Happy new year! At PropThink, our goal has always … Continue Reading
Read NowOne and One from Last Week’s Recap
Recap - Merry Christmas and Happy Holidays! Wishing you and yours a spectacular 2015! We were one and one in last week’s healthcare recap. The v-bottom played out as many expected, … Continue Reading
Read Now